Response to Comment on: Chakera et al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia due to a Glucokinase Mutation Requires Treatment. Diabetes Care 2012;35:1832–1834 | Zendy

Ali Chakera | Zendy; Victoria L. Carleton | Zendy; Beverley M. Shields | Zendy; Glynis P. Ross | Zendy; Andrew T. Hattersley | Zendy

Open Access

Response to Comment on: Chakera et al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia due to a Glucokinase Mutation Requires Treatment. Diabetes Care 2012;35:1832–1834

Author(s) -

Ali Chakera,

Victoria L. Carleton,

Beverley M. Shields,

Glynis P. Ross,

Andrew T. Hattersley

Publication year - 2012

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc12-1497

Subject(s) - medicine , amniocentesis , glucokinase , fetus , pregnancy , diabetes mellitus , obstetrics , chorionic villus sampling , mutation , genetic testing , prenatal diagnosis , endocrinology , genetics , gene , biology

We appreciate the comments by Tartaglia et al. (1) in response to our study. We agree with Tartaglia et al. that maternal glucose management in glucokinase ( GCK ) pregnancy should be guided by knowledge of whether the fetus has inherited the mutation from the mother. In our article (2), we propose that fetal genetic testing should be performed if chorionic villus sampling (CVS) or amniocentesis is performed for …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research